PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial, page-637

Great Post @Quiltman

It's interesting given one of the 5 times MT mentioned we were possibly a takeover target in the Capital Raise Presentation was this quote below.

"So there's a real opportunity now that we have ODD, we've got our Phase 1 study results in the bag, we've got our Open Label Extension study humming away in the background, churning out results, survival results, tolerability results, we're becoming more and more of an attractive potential takeover target for a Pharmaceutical company, Mid Cap, Big Cap pharmaceutical company most likely in the US. " (30.50)

Interesting he was more specific about the location (US) and the size (Mid/Big Cap) of the Pharmaceutical company, versus just Big Pharma.

Havenots